[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Pages 30708-30709]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10892]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2020-0052; NIOSH-337]
Advisory Board on Radiation and Worker Health, Subcommittee on
Dose Reconstruction Review (SDRR) Meeting
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Subcommittee for Dose
Reconstruction Reviews (SDRR) of the Advisory Board on Radiation and
Worker Health (ABRWH). This meeting is open to the public, but without
an oral public comment period. The public is welcome to submit written
comments in advance of the meeting, per the instructions provided in
the address section below. Written comments received in advance of the
meeting will be included in the official record of the meeting. The
public is also welcome to listen to the meeting by joining the audio
conference (information below). The audio conference line has 150 ports
for callers.
DATES: The meeting will be held on July 29, 2020, 10:30 a.m. to 4:00
p.m., EDT.
Written comments must be received on or before July 24, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0052; NIOSH-337; NIOSH by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: National Institute for Occupational Safety and
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati,
Ohio 45226-1998.
Instructions: All information received in response to this notice
must include the agency name and docket number [CDC-2020-0052; NIOSH-
337]. All relevant comments received will be posted without change to
http://www.regulations.gov, including any personal information
provided. Instructions: All submissions received must include the
Agency name and Docket Number. All relevant comments received in
conformance with the https://www.regulations.gov suitability policy
will be posted without change to https://www.regulations.gov, including
any personal information provided. For access to the docket to read
background documents or comments received, go to https://www.regulations.gov.
Meeting Information: Audio Conference Call via FTS Conferencing.
The USA toll-free dial-in number is 1-866-659-0537; the pass code is
9933701.
FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated
Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C-24,
Cincinnati, Ohio 45226, Telephone (513) 533-6800, Toll Free 1(800)CDC-
INFO, Email [email protected].
SUPPLEMENTARY INFORMATION:
[[Page 30709]]
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and rechartered under Executive Order
13889 on March 22, 2020, and will terminate on March 22, 2022.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. SDRR was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters to be Considered: The agenda will include discussions on
the following dose reconstruction program quality management and
assurance activities: Dose reconstruction cases under review from Set
27, possibly including cases involving, Amchitka Island Nuclear
Explosion Site, Argonne National Laboratory, Fee Materials Production
Centers (``Fernald Plant''), General Electric--Vallecitos, Hanford,
Idaho National Laboratory, Lawrence Berkeley National Laboratory,
Lawrence Livermore National Laboratory, Nevada Test Site, Oak Ridge
Gaseous Diffusion Plant (``K-25''), Office of Science and Technology
Information (``OSTI''), Paducah Gaseous Diffusion Plant, Portsmouth
Gaseous Diffusion Plant, Savannah River Site, Y-12, and potentially
other Department of Energy and Atomic Weapons Employers facilities.
Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-10892 Filed 5-19-20; 8:45 am]
BILLING CODE 4163-18-P